Maitake for Integrative Cancer Care
CancerMaitake is an edible mushroom that is used for both its nutritional and medicinal properties. Human and animal studies have shown Maitake may help improve immune function; however, its effectiveness in people with cancer is not clear. The investigators aim to measure if Maitake has any immunomodulatory effects when given alongside conventional systemic cancer therapy.
null
Conditions de participation
-
Sexe:
ALL -
Âges admissibles:
18 and up
Critères de participation
Inclusion Criteria:
1. Adults (≥18 years of age)
2. Confirmed cancer diagnosis through biopsy or radiologic imaging
3. Undergoing systemic treatment with either chemotherapy or CD4/6 inhibitors
4. Currently receiving cancer treatment in Ontario, Canada
Exclusion Criteria:
1. Hematologic cancers
2. Previously received any mushroom supplement within 6 months prior to enrolment
3. Allergy to mushrooms or mushroom products
4. Diagnosis of diabetes
5. Currently taking hypoglycemic or anticoagulant medications
6. Currently receiving immune checkpoint inhibitors
7. Unable to attend in in-person visits in either Ottawa or Toronto
8. Any reason which, under the discretion of the Qualified Investigator or delegate, would preclude the patient from participating
Lieu de l'étude
Canadian College of Naturopathic Medicine - Integrative Cancer Centre
Canadian College of Naturopathic Medicine - Integrative Cancer CentreToronto, Ontario
Canada
Contactez l'équipe d'étude
The Centre for Health Innovation
The Centre for Health InnovationOttawa, Ontario
Canada
Contactez l'équipe d'étude
- Étude parrainée par
- The Canadian College of Naturopathic Medicine
- Participants recherchés
- Plus d'informations
- ID de l'étude:
NCT06323473